Retiro De Equipo (Recall) de Merge CADstream with software versions earlier than 5.2.6. Distributed prior to March 2008 CADstream version 5.2.6 and newer are not affected by this recall.

Según Department of Health, Therapeutic Goods Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en Australia que fue producido por Emergo Asia Pacific Pty Ltd T/a Emergo Australia.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    RC-2016-RN-00868-1
  • Clase de Riesgo del Evento
    Class II
  • Fecha de inicio del evento
    2016-06-30
  • País del evento
  • Fuente del evento
    DHTGA
  • URL de la fuente del evento
  • Notas / Alertas
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notas adicionales en la data
  • Causa
    This recall is due to a necessary modification to the cadstream difference threshold when used in conjunction with ge phased array uniformity enhancement (pure) for dynamic mri imaging & a lack of notification when cadstream detects the pure filter has been used.The pure feature is designed to minimise coil intensity variations through a calibration process & may affect the signal intensity values of images. for dynamic series, cadstream kinetic analysis relies on a consistent image acquisition protocol for each individual series in the dynamic series. if pure is applied to individual phases, it may change signal intensity values for the individual series, thus affecting the kinetics. this may result in a change in the amount of colour in the cadstream angiomap. scanning protocols and/or contrast agents that are inconsistent with background filter multiplier settings may result in a sub-optimal angiomap. this may result in a delay in diagnosis or treatment, or patient misdiagnosis.
  • Acción
    Merge has released software fix for this issue. The CADstream software fix will detect when a PURE filter is being used and display a notification to the end user. Emergo is providing users with a set of work around instructions to follow as an interim measure. This acion has been closed-out on 27/02/2017.

Device

  • Modelo / Serial
    Merge CADstream with software versions earlier than 5.2.6. Distributed prior to March 2008 CADstream version 5.2.6 and newer are not affected by this recall.ARTG Number: 165390
  • Manufacturer

Manufacturer